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RHEUMATOID ARTHRITIS (RA) is a systemic, chronic inflammatory disease that is characterized by elevated proinflammatory cytokine levels, synovial inflammation, and cartilage and bone loss (44) . The mechanisms by which the disease is triggered are yet to be elucidated. More work has, however, been done in characterizing the disease pathophysiology and understanding the mechanisms of disease progression. It has been well documented that clinical symptoms in RA patients exhibit pronounced circadian rhythms with increased pain and stiffness in the early morning hours coinciding with the start of active phase (61) . This variation in disease severity is correlated with the circadian rhythms of proinflammatory cytokines. Furthermore, the hypothalamic-pituitary-adrenal (HPA) axis, a critical component of the neuroendocrine system, has been shown to modulate the secretion of proinflammatory cytokines and is thought to be an important regulator of disease activity (25) . A number of investigators have hypothesized that adrenal insufficiency, the inability of the HPA axis to mount an adequate anti-inflammatory in response to ongoing chronic inflammation in RA, might contribute to disease pathophysiology (64) . Moreover, a disruption in the circadian rhythms of cortisol has been observed in adjuvant-induced arthritis, as well as in patients with high disease activity (61) . A mechanistic understanding of the complex interactions between the HPA axis and the proinflammatory cytokines of the immune system can provide important insights into RA pathophysiology and the optimization of treatment regimens. In this regard, mathematical modeling has been used to support systems-level investigations aimed at understanding how circadian dynamics arising due to interactions between multiple physiological systems contribute toward overall disease pathophysiology (45) .
Animal models of RA have been used extensively to study disease pathogenesis and in the testing of anti-arthritic agents. Rodent models of arthritis are currently the most popular and have been developed in both rats and mice (2, 31) . This is largely due to their relatively low cost and the ability to work with genetically homogeneous populations. Adjuvant-induced arthritis in rats was the first animal model of RA developed and is induced by injection with complete Freund's adjuvant. This model has been widely used for the evaluation of new pharmaceuticals for chronic inflammatory arthritis (31) . It is characterized by robust polyarticular inflammation, bone resorption, and relatively mild cartilage destruction (4) . Rodent models of collagen-induced arthritis (CIA) are among the most extensively studied animal models of RA and are considered by some to be gold standard in vivo model for RA studies, since the lesions in CIA are more analogous to those seen in RA (4) . CIA is induced by inoculation with heterologous type II collagen in complete Freund's adjuvant (31) . Similar to RA, the major pathological features of CIA include synovial overgrowth, pannus formation, polymorphonuclear and mononuclear cell infiltration, cartilage and bone degradation, and fibrosis. Moreover, the primary cytokines mediating the CIA pathophysiology are tumor necrosis factor (TNF-␣), interleukin-1␤ (IL-1␤), and interleukin-6 (IL-6). Taken together, these features of CIA pathophysiology make it a particularly useful model for RA.
In this work, we discuss the development of a mathematical model with the aim of identifying the types of regulation in a signaling network that can yield results that qualitatively represent the important circadian pathophysiological features of experimentally induced models of arthritis. In doing so, we evaluate the dynamic interactions between the HPA axis and proinflammatory cytokines, and their downstream effects on paw edema, a key disease end-point in experimentally induced arthritis models. In particular, we investigate the changes in circadian rhythms of key HPA axis mediators, such as corticosterone (CST) and proinflammatory cytokines after induction of CIA that ultimately result in circadian variability in paw edema. Moreover, we simulate the phenomenon of adrenal insufficiency that has been observed in both CIA as well as RA patients (64) .
METHODS
We develop a mathematical model to study the dynamics between critical components of the neuroendocrine and immune systems in rodent models of induced arthritis. The model accounts for circadian variability in the expression of primary mediators of the HPA axis, proinflammatory cytokines, and a critical disease endpoint in characterizing severity of experimental arthritis: paw edema. Furthermore, we account for the light-mediated entrainment of the autonomous oscillations of these neuroendocrine-immune mediators. The model builds on our laboratory's previous work (18, 43, 50, 58) and is essentially composed of three components: a central oscillatory compartment that simulates the circadian secretion of CST (18) in the HPA axis, a peripheral compartment that captures the downstream effects of secreted CST on proinflammatory cytokine expression, and, finally, a compartment that accounts for the disease endpoints, specifically, paw edema. A schematic illustrating the various glucocorticoid and cytokine signaling pathways considered in our model is shown in Fig. 1 .
HPA axis and glucocorticoid receptor dynamics. The central compartment describes the self-sustaining circadian release of CST from the HPA axis, as a result of the negative feedback loop formed between corticotrophin-releasing hormone (CRH), adrenocorticotropic hormone (ACTH), and CST itself. This central signaling pathway is approximated mathematically by Eqs. 1-4, which represent a Goodwin oscillator modified to include MichaelisMenten degradation kinetics in the hypothalamic, pituitary, and adrenal regions to avoid the use of unrealistically high Hill coefficients (24) . Briefly, CRH production in the hypothalamus is described by a zero-order synthesis term and results in the production of ACTH in the pituitary (Eq. 3). ACTH is released into systemic circulation and eventually stimulates the secretion of CST from the adrenals. This is accounted for by the first-order synthesis term for CST (Eq. 4). Finally, the glucocorticoid receptor (GR)-mediated effects of CST result in inhibition of ACTH and CRH secretion, thus closing the negative feedback loop. There is evidence that the basal dynamics of the HPA axis are characterized by Model schematic for glucocorticoid and cytokine interregulation during arthritis progression. The two tolerance mechanisms are depicted in red. CST, corticosterone; ACTH, adrenocorticotropic hormone; CRH, corticotropin-releasing hormone; GR, free glucocorticoid receptor; GRmRNA, glucocorticoid receptor mRNA; DR, cytoplasmic corticosterone-bound GR; DR(N), nuclear corticosterone-bound GR; M, tolerance mediator; TCCytn, cytokine transit compartment. Please refer to Table 1 for definition of all rate constants.
both a circadian as well as a pulsatile ultradian rhythm (57) . However, for simplicity, our model approximates the true dynamics by accounting for only the circadian rhythmicity of the HPA axis. Furthermore, the free-running circadian rhythms of the HPA axis are entrained by the hypothalamic suprachiasmatic nucleus to a 24-h period. The suprachiasmatic nucleus integrates photic signals from the environment and functions as the central endogenous pacemaker of the physiological circadian clock (16) . Arginine vasopressin (AVP) release, which is induced by light, has been shown to strongly inhibit the release of CRH and, consequently, adrenal CST in rats (30) , while it is shown to have a stimulatory effect on HPA axis activity in humans (35) . Therefore, vasopressin release is responsible for low levels of circulating CST levels in the inactive phase of nocturnal animals. These observations suggest that inhibitory and excitatory effects of vasopressin release in rats and humans, respectively, is not due to the direct action of vasopressin on CRH neurons but due to activation of inhibitory or excitatory neuronal pathways regulating the release of CRH (57) . Therefore, we hypothesize that light entrains the rhythm of CST to a 24-h period by regulating the degradation of CRH (43) (Eq. 1).
We use a pharmacodynamic glucocorticoid model previously developed by our group to describe the dynamics of GR signaling in both the HPA axis, as well as in the peripheral (per) cells (50) . The model simulates the transcription of GR mRNA (GR mRNA) and the subsequent translation of GR protein (GR) (Eqs. 8, 9, 13, and 14) . Briefly, CST binds to cytokine-dependent (cyt) GR to form a complex, DR, after which a fraction of the complex is eventually translocated to the nucleus, DR(N). Once in the nucleus, the hormone-receptor complex binds to multiple downstream glucocorticoid responsive elements (GREs) to mediate its regulatory effects.
light ϭ 1 from 6 : 00 AM Ͻ t Ͻ 6 : 00 PM else, light ϭ 0 (2)
Mechanism B:
Cytokine activation of glucocorticoid signaling. It has been well established that proinflammatory cytokines, such as IL-1␤, IL-6, and TNF-␣, are potent activators of the HPA axis (17) . In vivo evidence strongly suggests that the activation of the HPA in response to acute inflammatory stress is strongly dependent on pituitary and hypothalamic CRH expression (17) . However, a number of studies demonstrate that, despite elevated CST levels, there is decreased CRH expression at the onset of inflammation in response to chronic inflammatory adjuvant-induced arthritis, with minimum CRH expression being reached at peak disease severity (1, 26, 29) . This paradoxical decrease has been observed in Lewis (7), Wistar (10) and PiebaldViral-Glaxo (26) strains of rat and is thus thought to be a common mechanism in the pathogenesis of adjuvant-induced arthritis. Taking these observations into consideration, we postulated that proinflammatory cytokines activate the HPA axis independently of CRH. This is mathematically represented by the proinflammatory cytokine term in Eq. 3 .
In developing our model, we also consider the effects of chronic inflammation on GR signaling dynamics. It has been established that the proinflammatory cytokines TNF-␣, IL-1␤, and IL-6 upregulate the expression of the GR mRNA (66) . Studies by Earp et al. (19) have demonstrated increased GR mRNA expression in CIA, suggesting that proinflammatory cytokines upregulate GR mRNA expression. We represent this positive regulation by the cyt synthesis term in GR mRNA equations in both central and peripheral compartments (Eqs. 8 and 13).
Proinflammatory cytokine dynamics. Cytokines are considered to be the most important molecular mediators in the pathogenesis of RA. For instance, it is thought that the deterioration of articular cartilage and the surrounding bone is largely facilitated by proinflammatory cytokines, such as IL-1␤, IL-6, and TNF-␣, both in human RA, as well as in animal models of the disease. For simplicity, we consider a single lumped cytokine term to describe the time course of proinflammatory cytokines after induction of the disease. We model the transcription of cytokine mRNA in peripheral cells and the subsequent translation of the protein in Eqs. 17 and 18. Peripheral CST inhibits the production of the cytokine mRNA through a GR-mediated indirect response mechanism, and in our model is also assumed to be responsible for generating the cytokine circadian rhythm. Moreover, the peripheral cytokine protein is also transported to the HPA, where it can stimulate neuroendocrine activity. The delay in cytokine signal to the HPA axis is applied by using a single transit compartment with a mean transit time of ϳ10 min (Eq. 21). This is in agreement with experimental observations where IL-1␤ administration in vivo results in increased ACTH secretion with ϳ5-10 min (66) .
In general, a delay is observed in the onset of cytokine upregulation once the animals are inoculated. We model this delay by simple transduction using a sequence of transit compartments. The number of transit compartments can be adjusted to fit an experimentally observed time delay, as was done in our laboratory's previous work (18, 19) . However, since we are interested in a qualitative model of disease progression, we choose a number of transit compartments that are representative of the experimentally observed delay (Eqs. 19 and 20) . To simulate the induction of the disease, the value of k dis in Eq. 17 is increased to a new disease steady-state value, while in simulations of healthy animals, kdis ϭ 0.
Finally, we attempt to simulate the phenomenon of adrenal insufficiency, which refers to perceived inability of the HPA axis to mount an effective anti-inflammatory response to the elevated cytokine levels observed in chronic RA and animal models of the disease. A number of theories have been proposed to explain the onset of adrenal insufficiency in chronic inflammatory diseases. Straub et al. (63) suggest that, in contrast to the situation in acute inflammation, chronically elevated proinflammatory cytokine levels inhibit HPA axis activity, resulting in the low HPA axis response relative to ongoing inflammation. On the other hand, Edwards (20) has recently proposed that proinflammatory cytokines stimulate 11␤-hydroxy steroid dehydrogenase (41) , an enzyme that catalyzes the conversion of inactive cortisone to cortisol. This results in increased cortisol levels, which negatively feed back to the HPA axis and inhibit further cortisol secretion. Ultimately, these theories suggest that the apparent adrenal insufficiency is due to downstream effects of proinflammatory cytokine signaling in chronic inflammation. Recent work by Wolff et al. (68) demonstrated that CST shows an initial increase in response to elevated proinflammatory cytokines in CIA rats, followed by an eventual decline, suggesting the onset of tolerance as the disease progresses. Thus we postulate an indirect response tolerance mechanism to model this phenomenon. Indirect response models are frequently used in pharmacokinetic/pharmacodynamic models and were originally used to capture a delay in the response of a measured variable of interest in response to a stimulus of interest especially, when the intermediate events between the onset of the stimulus and the response of the measured variable cannot be explicitly stated (55) . Since the complex regulatory mechanisms involved in the onset of adrenal insufficiency are yet to be elucidated, we find indirect response modeling particularly appealing in capturing the possible implicit interactions between variables of interest (22) , which in our case are the interactions between CST and proinflammatory cytokines. Therefore, we use an indirect response tolerance mechanism where chronically elevated cytokine levels lead to the stimulation of a hypersensitive tolerance mediator, M (Eq. 7). We consider two hypothetical mechanisms by which this tolerance mediator might act on the HPA axis to reduce CST secretion relative to ongoing inflammation under chronic conditions. In the first, mechanism A, we assume that activated tolerance mediator inhibits HPA axis signaling. This is represented in Eqs. 3 and 4, where M effectively acts to decrease ACTH concentrations, by increasing the clearance of ACTH in arthritic conditions, and thereby reducing CST secretion. In the second mechanism (mechanism B), the activated tolerance mediator instead further increases CST concentrations (Eqs. 5 and 6) in response to chronically elevated proinflammatory cytokine levels. We hypothesize that the increased CST levels would result in greater negative feedback to the HPA via a GR-mediated mechanism (Eq. 8), leading to the eventual desensitization of the HPA under conditions of chronic inflammation. Due to the hypersensitive response of M, homeostatic levels of cytokines, like those present in healthy controls, do not activate the tolerance mechanism. Parameter values for both mechanisms are presented in Table 1 .
where n ϭ 15.
Paw edema dynamics. We consider paw edema as an indicator of disease severity in arthritic conditions. Paw edema progression is modeled as a result of the stimulation by proinflammatory cytokines and loss of the produced edema through a first-order decay term. We hypothesize that a slight delay exists between the onset of increased proinflammatory cytokine expression and onset of the rise in paw edema. For instance, it has been observed that levels of cytokines, chemokines, and cytokine receptors were significantly higher before disease onset in individuals who subsequently developed RA compared with control subjects who did not develop RA (33) . This delay is incorporated by making the rate constant for paw edema generation dependent on the final cytokine transit compartment, TC_Cyt n. Moreover, this enables us to avoid circadian variation in the paw size during healthy conditions.
Cosinor rhythmometry analysis. Cosinor rhythmometry is a commonly used technique in the analysis of both experimental and simulated circadian data. We employed cosinor analysis to estimate characteristic parameters of the circadian rhythms of the neuroendocrine-immune mediators. This enabled us to quantitatively evaluate changes in circadian rhythm of various model species in our simulations of chronic inflammation.
Briefly, cosinor analysis involves the fitting of a sinusoid to the dataset using nonlinear regression. Depending on the nature of the data, one can attempt to fit a single component sinusoid, or multiple sinusoids. For the purposes of our simulation, we were able to achieve sufficient resolution with a single-component sinusoid.
Thus the regression model can be represented as
where M is the MESOR (Midline Estimating Statistic Of Rhythm) (the MESOR is a rhythm adjusted mean); 2A is the measure of the predictable change within the data (the amplitude); is the acrophase of the rhythm; is an estimate of the period of oscillation; and ε are the errors accounting for the difference between model predictions and data observations. Sensitivity analysis. A local sensitivity analysis is performed to gain insight into the CST dynamics predicted by our model both in the nominal healthy state and in response to the elevated cytokine levels in the arthritic state. As in previous studies by our group (52) and others (58), we use a relative sensitivity coefficient computed as the product of the absolute sensitivity function (the partial derivative of the of the response variable to changes in the parameter of interest) and the ratio of the nominal value of the parameter to the nominal output of the signal.
where NM are the number of measures; y is the state variable whose response is being studied; and pk are the parameters of interest.
Since we were primarily interested in the dynamics of CST predicted by the model, we use its profile as the response variable in calculating the sensitivity coefficients. Parameters are individually varied by 1%, and the sensitivity coefficients are calculated (9) for each parameter accordingly. For the simulated arthritic state of the model, parameters are perturbed before the simulated onset of the disease to determine the change in response of the system to elevated disease state proinflammatory cytokine levels.
RESULTS
Our model aims to characterize the effects of chronic inflammation on the circadian dynamics of proinflammatory cytokines and HPA axis hormones. Figure 2 shows the time course of cytokines both in simulated healthy control conditions, as well as in arthritic conditions. The disease was induced at an arbitrarily selected time, t ind Ͼ 0, in order to enable visual comparison of changes in cytokine levels before and after disease induction. A noticeable delay is observed in the upregulation of proinflammatory cytokines after disease induction, together with a marked loss in circadian rhythm. Furthermore, cytokine levels remain elevated over the entire time course of the simulated experiment, thus indicating a state of chronic inflammation. These features are in qualitative agreement with results from experimental models of RA (19) . Figure 2 also shows the corresponding time course of CST, while Fig. 3 shows the time course for CRH and ACTH, for both mechanisms of adrenal insufficiency. Cosinor analysis (Table 2) demonstrates that the circadian rhythm of the HPA axis hormones is entrained by light to a steady-state 24-h period over the entire time course of the simulated experiment. Interestingly, both postulated mechanisms of the adrenal insufficiency (mechanisms A and B) yield qualitatively similar profiles of HPA axis mediators. Model simulations predict a marked increase in the CST levels corresponding to the upregulation of proinflammatory cytokine levels after disease induction (Fig. 2, C and D) . This increase in CST levels is accompanied by a slight decrease in the amplitude of CST oscillations. However, these CST levels are not maintained, and there is an eventual decrease in mean CST release in response to chronically elevated cytokine levels, due to the activation of the postulated tolerance mechanism. Moreover, this decrease is accompanied by a further loss in circadian rhythmicity of CST. Cosinor analysis reveals that, although mean CST levels decrease, they do not return to the levels present in healthy controls and remain slightly elevated for the entire duration of the simulated experiment.
On the other hand, there is a significant decrease in the mean expression of CRH (Fig. 3, C and D) , despite the increase in CST levels. Although CRH levels increase slightly after the activation of tolerance mediator, they remain distinctly lower compared with levels in healthy controls. Similar to the other HPA axis hormones, ACTH (Fig. 3, A and B) also shows a discernable decrease in amplitude of oscillation after induction of the disease. There is a substantial decrease in diurnal ACTH maxima and a slight increase in its diurnal minima. Interestingly, model simulations predict that maximum CST levels show a relatively small decrease, despite the marked decrease in maximum ACTH levels, as revealed by respective time course profiles (Fig. 3, A and B) , as well as the cosinor analysis.
We further consider GR dynamics in response to changes in CST and cytokine levels. We find that both GR protein and mRNA initially show a sharp decrease in expression corresponding to transient increase in CST levels and onset of increased proinflammatory cytokine levels (Fig. 4) . However, there is an eventual increase in both GR mRNA and protein levels after the onset of tolerance compared with those observed in the healthy state accompanied by a decrease in amplitude of oscillation. Figures 5 and 6 compare the circadian profile of the HPA axis hormones, proinflammatory cytokines, and GR expression over a 48-h time period, representative of the rhythm in healthy controls and after the onset of tolerance for both mechanisms, respectively. It can be seen that the CRH and ACTH profiles peak slightly earlier than the CST profile, accounting for the time required for the signal transduction along the HPA axis. Moreover, it can be seen from the cosinor analysis that CST profiles peak just before the onset of the dark period. A number of experimental studies have established that CST levels peak slightly before the start of the active phase, which is during the dark period for nocturnal animals, such as rats considered in our model (69) . The decrease in amplitude and change in mean value of oscillation are clearly discernible in these profiles. Furthermore, there is a noticeable shift in the phase of oscillation toward earlier time points in the circadian profiles for ACTH, CST, proinflammatory cytokines, as well as GR mRNA and protein. Using cosinor analysis, we estimated this change in phase to be ϳ10 h.
Model simulations predict a constant steady-state paw size for healthy control simulations. However, there is almost a threefold increase in paw size due to the formation of paw edema as a result of the chronically elevated proinflammatory cytokines (Fig. 7, A and B) . A diurnal variation in paw edema is evident in the simulated arthritic state (Fig. 7, C and D) . Moreover, comparing the circadian rhythms of proinflammatory cytokines and paw edema (Fig. 7, E and F) , it can be observed that this rhythmic variation in the disease end-point is well correlated to the circadian rhythm exhibited by the proinflammatory cytokines in the arthritic state.
Sensitivity coefficients for each parameter are calculated as shown in Eq. 24 . The results of the sensitivity analysis are shown in Fig. 8 for both of the mechanisms. The magnitude of the sensitivity coefficients are comparable to models that our laboratory has previously developed (52) . The analysis reveals that, in the healthy state, which is considered to be the nominal state of the system, the model output is most sensitive to perturbations in estimated parameters associated with Goodwin oscillator of the HPA axis (i.e., Eqs. [1] [2] [3] [4] [5] [6] . Furthermore, the sensitivity coefficients for most of the parameters are lower in the arthritic state of the model than in the healthy state of the model. Fig. 4 . Time course of GR when onset of tolerance is due to mechanism A (A) and mechanism B (B), and time course of GR mRNA when onset of tolerance is due to mechanism A (C) and mechanism B (D). Inset images depict the circadian profile in indicated regions of the time course profiles of the respective mediator.
DISCUSSION
The neuroendocrine hormonal regulation of the immune system has received a great deal of research attention in relation to its importance in the pathophysiology of chronic inflammatory diseases. Rheumatologists routinely administer glucocorticoids in the treatment of RA due to their potent anti-inflammatory and anti-proliferative effects (6, 8, 14) . Moreover, a number of studies have investigated the possibility of altered endogenous glucocorticoid regulation by the HPA axis in rheumatic diseases.
In general, increased glucocorticoid secretion is observed in studies on animal models of both adjuvant-induced arthritis and CIA. Evidence suggests that cortisol levels in RA patients with low to moderate disease activity remain largely unchanged compared with that in healthy controls, whereas patients with severe RA show elevated cortisol levels (61) . However, it is widely considered that the anti-inflammatory glucocorticoid response is inadequate in relation to the ongoing inflammation in both RA and animal models of the disease (15, 48, 51, 60, 68) . This phenomenon, termed adrenal insufficiency, is generally evaluated by comparing the glucocorticoid hormone-to-proinflammatory cytokine ratio in arthritic conditions to that in healthy control conditions (64) . In a recent study by Wolff et al. (68), a marked increase in CST levels was observed on day 1 after induction of CIA in rats. However, CST concentrations returned to levels comparable to those in healthy controls by day 5, despite IL-1␤ levels showing a steady increase over the duration of the experiment. This behavior was also observed for ACTH expression in the same study. In agreement with the general pathological features exhibited in experimental studies, our model simulations reveal a transient rise in CST levels due to the upregulation of proinflammatory cytokines, regardless of the mechanism of adrenal insufficiency. This transient increase is due to activation of the HPA axis as a result of upregulated cytokine levels soon after disease induction. Subsequently, the model predicts that this increase in CST levels is quickly followed by the onset of tolerance. This results in a relative decrease in CST levels, although they are still significantly elevated compared with CST levels in healthy controls. Therefore, taken together, our simulations suggest that, as in the phenomenon of adrenal insufficiency, the HPA axis cannot mount a sustained antiinflammatory response in the presence of chronically elevated levels of proinflammatory cytokines.
Despite the increase in CST levels, our model simulations reveal that CRH expression decreases in arthritic conditions compared with healthy controls. As discussed in previous sections, a number of studies report a paradoxical decrease in CRH levels, despite the increased HPA axis activity. Conversely, it has been observed that the decrease in CRH levels in adjuvant-induced arthritis is accompanied by an increase in the AVP expression. Therefore, it has been hypothesized that AVP may be the primary mediator responsible for the observed increase in HPA axis activity in response to chronic inflammatory conditions in adjuvant-induced arthritis (11, 26) . Furthermore, a number of studies demonstrate that vasopressin is an inhibitor of CRH secretion in nocturnal animals, such as rats and mice, with increased vasopressin activity being correlated with decreased CRH expression (30) . Evidence suggests that the observed CRH decrease as a result of altered HPA axis activity is characteristic of the pathophysiology of a number of other experimental models of immune-mediated diseases, such as experimental allergic encephalomyelitis (42), eosinophilia-myalgia syndrome (7), and systemic lupus erythematosus (25, 54) .
It has been established that a multitude of biological processes, critical to the maintenance of homeostasis, are under precise circadian regulation. Chronic circadian disruption has been implicated in increasing the susceptibility to a number of chronic inflammatory diseases, including RA, diabetes, obesity, and cancer (23, 47, 67) . Furthermore, a number of studies report a disruption of neuroendocrine and immune circadian rhythms in human and experimental RA. A number of studies on the animal model of adjuvant-induced arthritis have observed that elevated CST levels have been associated with a blunted circadian rhythm (9, 51, 53) . Interestingly, this has also been observed (48) (13, 61) in patients with high RA activity. In a study by Sarlis et al. (51) , which studied HPA axis activity in adjuvant-induced arthritis, it was observed that CST and ACTH levels were higher in the inactive phase compared with healthy controls. Similar behavior was observed in salivary cortisol levels in patients with high disease activity, where cortisol levels did not significantly drop after the afternoon maximum (15) . Model simulations seem to be in general agreement with these experimental observations. Our simulations describe a loss in CST rhythm, as indicated by the decreased amplitude and, furthermore, show that, while the diurnal maxima for CST is largely unchanged, the diurnal minimum is markedly elevated.
On the other hand, in our simulations, the diurnal peak of the ACTH circadian rhythm is clearly lower, while its minima is elevated. Mean ACTH levels are slightly higher when the onset of tolerance is due to mechanism A, while they are lower when adrenal insufficiency is achieved by mechanism B, as shown by the mesor value in the cosinor analysis (Table 2) . Considering the striking decrease in the circadian peak of ACTH, it is interesting to note that the corresponding maximum for CST is substantially unchanged. Although such a finding has not been corroborated by experimental studies with animal models of RA, Straub et al. (65) observed that RA patients had a higher cortisol-to-ACTH ratio compared with healthy controls. Moreover, RA patients with a relatively lower cortisol-to-ACTH ratio were more likely to respond positively to anti-TNF-␣ therapy than patients with a high cortisol-to-ACTH ratio. Under healthy conditions, it is considered that the cortisol-to-ACTH ratio is strictly regulated; however, under arthritic conditions, it is hypothesized that this ratio increases due to alterations in regulatory network between the HPA axis and adrenals glands, resulting in cortisol secretion being seemingly decoupled from the corresponding ACTH signal. A possible cause for this decoupling could be attributed to the ability of proinflammatory cytokines to stimulate the cortisol secretion from the adrenals independently of the HPA axis (21, 65) . Our model suggests that such an observation might be due to the increased negative feedback from the cytokine-induced increase in CST levels to CRH and ACTH, resulting in lower levels of these mediators.
Model simulations also predict an initial decrease in GR mRNA and protein expression, followed by an eventual increase to a level higher than the corresponding expression levels in healthy controls. In agreement with our results, Earp et al. (19) observed an increase in GR mRNA expression following induction of the disease in CIA rats.
IL-1␤ and TNF-␣ are widely considered to be the primary mediators of chronic inflammation in RA. Experimental evi- Fig. 7 . Paw edema progression over time course of simulation when onset of tolerance is due to mechanism A (A) and mechanism B (B), and circadian variation of paw edema in arthritic conditions when onset of tolerance is due to mechanism A (C) and mechanism B (D). Paw size in healthy controls is maintained at a constant value in healthy controls. Comparison is shown of circadian rhythm of proinflammatory cytokines and circadian rhythm in paw edema in arthritic conditions when onset of tolerance is due to mechanism A (E) and mechanism B (F). Note the change in y-axis scale in C, D, E, and F.
dence from both animal models and human patients seems to support this view (27, 68) . However, often IL-6 is used as a marker for chronic inflammation in RA, as it is the most easily measureable of the three primary proinflammatory cytokines (68) . Cytokine levels in both animal models of the disease, as well as RA patients, are found to be up to 10 times as high as in healthy controls (12, 19) . The cytokines in our simulation results have a threefold increase in mean levels. Furthermore, Seres et al. (53) report that the circadian rhythm of IL-1 is suppressed in adjuvant-induced arthritis, while the amplitude of IL-6 circadian expression increases. A suppression of cytokine rhythms has also been observed in fibroblasts isolated from the synovium of RA patients compared with synovial fibroblasts isolated from osteoarthritic patients (34).
Furthermore, simulation results also show an advance in the phase of the circadian rhythm for both neuroendocrine hormones as well as the cytokines. This suggests that alterations in HPA axis signaling regulation in response to chronic inflammation might result in the observed phase advance. Our model simulations are in qualitative agreement with these findings from both animal models and human studies. Seres et al. (53) report a phase advance in IL-1␤ circadian rhythm, but a phase delay in the circadian rhythm of IL-6 in a model of adjuvantinduced arthritis. Furthermore, Li et al. (39) showed that rats with CIA exhibited a significantly earlier and higher IL-6 peak, with a nearly inverted CST rhythm. However, other studies report a broadening of the cytokine peak with a shift to later times of the day, resulting in an effective rise in amplitude (61). It is well established that the expression of proinflammatory cytokines is regulated by the expression of components of the circadian clock, including Cry (47), Bmal1 (49) , and Clock (56) . However, in our model, cytokine oscillations are driven only by CST oscillations, and we do not explicitly account for circadian clock control of cytokines. This might be able to explain some of the discrepancy between experimental findings and the cytokine phase relationships predicted by our model.
The sensitivity analysis reveals that the parameters associated with the Goodwin oscillator have the highest sensitivity coefficients of the estimated parameters (parameters 6, 8, and 9) . This is expected considering that the dynamics of the model are largely determined by the equations representing the Goodwin oscillator ( Eqs. 1-6) . Furthermore, since we use the CST profile as the primary response variable in calculating the sensitivity coefficients, it is not surprising that k p3 , the rate of CST synthesis, and V d3 , the rate of enzymatic degradation of CST (parameters 8 and 9, respectively) are among the most sensitive parameters. Furthermore, the parameters associated with the dynamics between CST and the GR (parameters 16 and 19, which were obtained from literature) also contribute significantly to model sensitivity. The model output is probably sensitive to perturbations in these parameters, since they directly influence the amount of DR(N), which determine the extent of CST feedback to CRH and ACTH. Interestingly, the sensitivity analysis of a similar model of the HPA axis by Sriram et al. (58) also found that the model output was most sensitive to perturbations in parameters associated with GR dynamics. Notably, the model is much less sensitive to perturbations in parameters in the arthritic state than in the nominal healthy state as can be observed from the lower values of the sensitivity coefficients (Fig. 8) . This is likely due to the relatively strong feedback term of the elevated cytokine levels to the HPA axis equations, forcing the system toward a more stable state. Such a response is applicable to experimental models of arthritis, such as adjuvant-induced arthritis and CIA, which are generally used to model the severe late stage of the disease (5, 46) primarily associated with high levels of monokines such as TNF-␣ and IL-1␤ (59) .
Finally, it is well established that disease-related symptoms in patients of chronic inflammatory diseases, such as RA, exhibit distinct circadian rhythms (3, 12, 28, 36, 37, 61) . For instance, patients report maximum severity of symptoms, such as joint pain, stiffness, and functional disability in the early morning hours (start of the active phase), with mild to moderate disease active in the evening (end of the active phase). Furthermore, it is observed that the diurnal variation in disease symptoms is well correlated with the circadian rise in the levels of proinflammatory cytokines and, conversely, the circadian decrease in levels of CST. Circadian rhythms have also been observed in rodent models of experimental inflammation, such as carrageenan-induced paw edema (38, 40) . Our model simulations are in qualitative agreement with these experimental observations, where the paw edema peak is correlated to the cytokine peak.
In conclusion, our model qualitatively captures key features of RA pathophysiology. Through the model simulations, we are able to relate chronic upregulation of proinflammatory cytokine with incidence of adrenal insufficiency and the circadian disruption of critical mediators of the neuroendocrine and immune systems. We also show that both postulated mechanisms of adrenal insufficiency result in qualitatively similar profiles of neuroendocrine and proinflammatory mediators. Furthermore, our work highlights the importance of accounting for circadian dynamics while studying the interactions between the neuroendocrine and immune signaling pathways. It is interesting to note that loss in amplitude and change in phase of the rhythms resulted solely from the model dynamics and were not explicitly accounted for in the model equations. Our model suggests that the activation of the postulated tolerance mechanisms results in the manifestation of symptoms characteristic of chronic inflammation in RA, such as a significant loss in diurnal rhythm of the HPA axis hormones and the supposed decoupling of ACTH and CST signaling. However, the model has some important limitations. The model assumes that the circadian rhythm of the cytokines is generated only as a result of the circadian rhythm of CST due to the Goodwin oscillator. However, it has been established that proinflammatory cytokines have their own intrinsic circadian rhythm and are regulated by the peripheral circadian clocks, independently of the HPA axis (32) . This limits the extent to which our model can capture the dynamics of the proinflammatory cytokines in the arthritic state. Furthermore, we do not consider the transition from the acute phase to the chronic phase of the disease, as is thought to happen in RA.
Although our model predictions are largely qualitative in nature, we were able to identify regulatory structures of signaling networks that could capture key pathophysiological features of the disease, such as the apparent adrenal insufficiency, loss of circadian amplitude in the arthritic state, and possible alterations in the phase of the rhythm of the HPA axis mediators. We consider two alternative hypothetical mechanisms for the onset of adrenal insufficiency, which yield qualitatively similar results. Future work could involve further incorporating the mechanisms by which regulatory intermediates (such as 11-␤ hydroxysteroid dehydrogenase) involved in the feedback of cytokines to the HPA axis might result in its altered signaling in both animal model of arthritis, as well as in the human disease. Thus the model developed here provides a foundation for further work on the significance of circadian rhythms in neuroendocrine-immune signaling in chronic inflammatory diseases.
